Académique Documents
Professionnel Documents
Culture Documents
org
Effect
Hypnosis Mehl-Madrona 2004 Martin 2001 Cyna 2011 Freeman 1986 Harmon 1990 Rock 1969 Werner 2013 520 42 305 59 60 40 723
0.99 [0.45, 2.20] Relative Risk 0.10 [0.24, 0.04] Mean Difference Favours Control
Figure 1. RCTs evaluating pharmacological analgesics used in labour in women who have received self-hypnosis training compared with control groups and evaluating coitus to induce labour.
2013 The Authors BJOG An International Journal of Obstetrics and Gynaecology 2013 RCOG
in the two arms of the study nor were there any differences in induction rates or premature rupture of membranes. So this relatively large RCT echoed the results of Bavold (Figure 1). From the limited evidence, vaginal coitus does not appear to inuence delivery outcomes, and its promotion can be dismissed from our antenatal clinics as an effective means of labour induction. What it does demonstrate is that there is no harm in having vaginal intercourse at term. Whether couples want to listen to evidence-based medicine or not is a different matter! The trial can be criticised as only 16% of women returned their coital diaries, so follow-up telephone interviews were made, which might allow scope for recall bias. Furthermore, sexual activity in the control arm was unexpectedly high, which might negate the effect of coitus in the control arm. So if there are any budding triallists out there who want to denitively answer this question, there is still scope for a future RCT.
Study year
Derman 2006 Mobeen 2010 Nasreen 2011 Sanghvi 2004
Sample size
1620 1072 1892 1488
Effect
0.64 [0.55, 0.74] Summary Relative Risk Favours Intervention Favours Control
Figure 2. Controlled studies comparing the risk of PPH after administration of misoprostol compared with control in home settings.
Should oral misoprostol be used to prevent PPH in home birth settings in low resource countries?
Postpartum haemorrhage (PPH) remains one of the leading causes of maternal death in sub-Saharan Africa and south-east Asia. In contrast to oxytocin, which tends to be given by birth attendants in birthing centres, misoprostol has attracted interest because it is inexpensive, does not require cold-chain storage, is administered orally, and can be administered by a non-skilled attendant. Community-based administration of misoprostol to women in developing countries in areas without skilled birth attendants will have a signicant impact on the prevention of PPH
with simulation models suggesting around a 40% reduction in incidence of signicant PPH. Hundley et al. on page 277 attempt to assess the evidence for misoprostol usage in low-resource countries. Two randomised and four non-randomised controlled studies were identied. Five studies in this review used a 600-lg dose of misoprostol; however, the most recent used a lower dose of 400 lg. In the majority of studies, a healthcare worker was trained to identify early warning signs of PPH and give the misoprostol accordingly. Four studies including the two RCTs used PPH >500 ml as an outcome measure and all four demonstrated a signicant reduction in signicant blood loss (Figure 2). Shivering and fever were the most common adverse effects. One concern is the inappropriate use of misoprostol as a stimulant of labour and administration before the birth of a second twin. It is therefore essential to have effective educational programmes for individuals and birth attendants. The overall conclusion is that oral misoprostol administered to women in low-resource countries signicantly reduces complications secondary to PPH. Its routine administration is likely to reduce the risk of maternal death in home settings.
nal circulated to approximately 11 500 members of the Royal College of Obstetricians and Gynaecologists, UK. From now on, we will select BJOG articles to have accompanying CPD questions published in TOG as part of the knowledge-based assessment requirement of the CPD programme. Authors of these selected articles will be invited to submit CPD creditable questions that can be answered using the information within their paper. Preparing questions is not an onerous task and guidelines will be available. Questions will be sent to TOG CPD editors for approval. The rst set of questions related to a BJOG paper appears in the January
2013 issue of TOG, which is free to view on Wiley Online Library (http://onlinetog.org). We envisage this exciting initiative to raise the prole, readership, citations and incorporation into practice of our papers. If you would like to have your papers considered for this initiative, please contact me at bjog@rcog.org.uk, giving reasons why you think your work will be suitable for CPD. &
2013 The Authors BJOG An International Journal of Obstetrics and Gynaecology 2013 RCOG